Case File
efta-efta00976405DOJ Data Set 9OtherFrom: Tazia Smith
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00976405
Pages
3
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Tazia Smith
To: "jeffrey epstein" leevacation®gmail.cotn>
Cc: "Paul Ma,
"Vahe Stepanian" <
Beller"
Subject: Re: INTC buy-and-write [C]
Date: Sat, 23 Nov 2013 13:27:43 +0000
Importance: Normal
Inline-Images: unnamed
>, "Harry
Classification: Confidential
Hi Jeffrey - With this I was proposing an at the money buy and write on INTC (the Dec at the money's were trading at a 1.7pct premium to
intrinsic, plus we like the underlier from a valuation and cash flow perspective. I apologize for the out of office alert - my team is in and
we are focused - communications will just be coming from the team (Paul, Vahe, Caroline) while I'm traveling. Vahe is cc'd here and we
are on top of your positioning. Same number 212-454-2889.
Tazia Smith
Director
Markets Coverage Group
Deutsche Bank Securities, Inc.
Deutsche Asset & Wealth Management
345 Park Avenue - 26th Floor
New York, NY 10154
Tel:
Mobile:
Fa
E-mail:
From: Jeffrey Epstein [[email protected]]
Sent: 11/23/2013 10:08 AM CET
To: Tazia Smith
Subject: Re: INTC buy-and-write [C]
what are you proposing???
On Fri, Nov 22, 2013 at 4:25 PM, Tazia Smith <
> wrote:
Classification: Confidential
Not fancy - INTC, down over 4.5% following a self-critical Analyst Day. DB is one of the only
analysts across the Street defending the name - in fact he raised his price target to 28 from 26. In
part, he thinks management is being conservative and setting up for outperformance., $2 eps for
2014E (current 12x vs large cap semi peers at 16x)
INTC spot is $24.09
Dec 23 calls are -$1.21 bid
Dec 24 calls are —$0.51 bid
EFTA00976405
INTO has a 3.7% current dividend yield, goes ex 2/5, reports 1/16 (Jan expiry is 1/18)
Tazia Smith
Director I Key Client Partners - US
Deutsche Bank Securities Inc
Deutsche Asset S Wealth Management
345 Park Avenue. 26th Floor
New York. NY 10154
Tel.
Fax
Mobil
Email
This communication may contain confidential and/or privileged information.
If you are not the intended recipient (or have received this communication
in error) please notify the sender immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of the
material in this communication is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This communication may contain confidential and/or privileged information.
If you are not the intended recipient (or have received this communication
in error) please notify the sender immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of the
material in this communication is strictly forbidden.
EFTA00976406
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
EFTA00976407
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Phone
212-454-2889Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.